Doctor of Podiatric Medicine Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Hugo Fernandez

Podiatrist, Foot & Ankle Surgery Miami, FL Doctor of Podiatric Medicine

NPI 1073928974 CMS profile 1048900

1401 Sw 107Th Ave Ste 301E, Miami, FL 33174

Open in the dashboard

General payments

$19,569

191 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Hugo Fernandez of Miami, FL is reported in the CMS Open Payments database as having received $19,569 across 191 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 91st percentile of Podiatrist, Foot & Ankle Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $21 1
2023 General $433 4
2022 General $3,663 31
2021 General $8,790 77
2020 General $2,539 30
2019 General $4,124 48

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Hugo Fernandez
  • Podiatrist, Foot & Ankle Surgery median
  • Middle half of Podiatrist, Foot & Ankle Surgery
  • National median

In program year 2025, general payments to Hugo Fernandez were reported at $21. Among 6,994 Podiatrist, Foot & Ankle Surgery profiles paid that year, the median was $424 and the middle half received between $139 and $1,306.

Show as a table
Year Hugo Fernandez Podiatrist, Foot & Ankle Surgery median Middle half National median
2019 $4,124 $389 $118–$1,406 $163
2020 $2,539 $191 $62–$691 $114
2021 $8,790 $329 $104–$1,341 $132
2022 $3,663 $419 $125–$1,611 $149
2023 $433 $377 $128–$1,164 $160
2024 $0 $394 $134–$1,168 $164
2025 $21 $424 $139–$1,306 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Stryker Corporation $10,460 108 payments
  2. Acumed LLC $2,804 16 payments
  3. Paragon 28, Inc. $1,203 2 payments
  4. Integra LifeSciences Corporation $825 13 payments
  5. Organogenesis Inc. $789 8 payments
  6. TissueTech, Inc. $630 2 payments
  7. Wright Medical Technology, Inc. $394 5 payments
  8. Smith+Nephew, Inc. $343 6 payments
  9. KCI USA, Inc $324 5 payments
  10. Osteomed LLC $241 2 payments
  11. Other $1,558 24 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $10,639 158 payments
  2. Travel and Lodging $8,486 29 payments
  3. Education $241 2 payments
  4. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $204 2 payments
Products named General payments · program years 2019–2025
  1. SALVATION $1,811 23 payments
  2. VARIAX $1,773 9 payments
  3. ANCHORAGE $1,680 23 payments
  4. PRIME SERIES $1,643 10 payments
  5. Acutrak Headless Compression Screw System $1,287 6 payments
  6. ACUMED Foot & Ankle $1,223 6 payments
  7. Product Portfolio $1,203 2 payments
  8. ACUMED Foot & Ankle $1,129 5 payments
  9. SPY-PHI SYSTEM $904 1 payment
  10. ACUMED Foot & Ankle $828 4 payments
  11. Other $16,931 199 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 5 drugs

Part D claims

221

Median for Podiatry: 160

Drug cost

$4,806

Median for Podiatry: $2,368

Branded share of claims

0%

Median for Podiatry: 12.7%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Ciclopirox Generic 87 $1,916
Ammonium Lactate Generic 61 $1,210
Ketoconazole Generic 50 $1,011
Clotrimazole Generic 11 $385
Diclofenac Sodium Generic 12 $283

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 14,093 Part D prescribers listed as Podiatry; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 10 billing codes

Paid by Medicare

$125,933

Medicare's payments for the services billed

Medicare patients

1,041

Average age 78

Services billed

2,785

599 women, 442 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Depression 75%
Alzheimer's or dementia 68%
Diabetes 51%
Arthritis 51%
Ischemic heart disease 42%
Chronic kidney disease 38%
Heart failure 36%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

191 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Podiatrist, Foot & Ankle Surgery in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record